Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Henzen

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
International Journal of Cancer|January 3, 1996
Differential regulation of breast tumor cell proliferation by stromal fibroblasts of various breast tissue sourcesK E van Roozendaal, J G Klijn, B van Ooijen, et al.
World Journal of Surgery|March 1, 1997
Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: new diagnostic methodJ Bonnema, A N van Geel, B van Ooijen, et al.
Cancer|November 15, 1994
Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon. An unexpectedly frequent complicationW H Kruit, K J Punt, S H Goey, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Quality control of immunohistochemical evaluation of tumour-associated plasminogen activators and related components. European BIOMED-1 Concerted Action on Clinical Relevance of Proteases in Tumour Invasion and MetastasisD J Ruiter, C M Ferrier, G N van Muijen, et al.
International Journal of Cancer|June 17, 1998
Urokinase-type-plasminogen-activator (uPA) production by human breast (myo) fibroblasts in vitro: influence of transforming growth factor-beta(1) (TGF beta(1)) compared with factor(s) released by human epithelial-carcinoma cellsA M Sieuwerts, J G Klijn, S C Henzen-Logmand, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parametersV Kuenen-Boumeester, T H Van der Kwast, C C Claassen, et al.
Journal of Endocrinological Investigation|January 9, 2016
Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptomsA Trombetti, E R Christ, C Henzen, et al.
The Journal of Pathology|November 5, 1999
Altered expression of p53 and its regulated proteins in phyllodes tumours of the breastV Kuenen-Boumeester, S C Henzen-Logmans, M M Timmermans, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot studyM E van der Burg, S C Henzen-Logmans, J A Foekens, et al.
British Journal of Cancer|October 1, 1996
Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumoursM Schuyer, I L van Staveren, J G Klijn, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
International Journal of Cancer|January 3, 1996
Differential regulation of breast tumor cell proliferation by stromal fibroblasts of various breast tissue sourcesK E van Roozendaal, J G Klijn, B van Ooijen, et al.
World Journal of Surgery|March 1, 1997
Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: new diagnostic methodJ Bonnema, A N van Geel, B van Ooijen, et al.
Cancer|November 15, 1994
Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon. An unexpectedly frequent complicationW H Kruit, K J Punt, S H Goey, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Quality control of immunohistochemical evaluation of tumour-associated plasminogen activators and related components. European BIOMED-1 Concerted Action on Clinical Relevance of Proteases in Tumour Invasion and MetastasisD J Ruiter, C M Ferrier, G N van Muijen, et al.
International Journal of Cancer|June 17, 1998
Urokinase-type-plasminogen-activator (uPA) production by human breast (myo) fibroblasts in vitro: influence of transforming growth factor-beta(1) (TGF beta(1)) compared with factor(s) released by human epithelial-carcinoma cellsA M Sieuwerts, J G Klijn, S C Henzen-Logmand, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parametersV Kuenen-Boumeester, T H Van der Kwast, C C Claassen, et al.
Journal of Endocrinological Investigation|January 9, 2016
Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptomsA Trombetti, E R Christ, C Henzen, et al.
The Journal of Pathology|November 5, 1999
Altered expression of p53 and its regulated proteins in phyllodes tumours of the breastV Kuenen-Boumeester, S C Henzen-Logmans, M M Timmermans, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot studyM E van der Burg, S C Henzen-Logmans, J A Foekens, et al.
British Journal of Cancer|October 1, 1996
Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumoursM Schuyer, I L van Staveren, J G Klijn, et al.
Pageof 11